
    
      1. To study the advantages and disadvantages of Neovas BRS and DCB in interventional
           treatment of de novo lesions in STEMI patients, in order to better guide the clinical.

        2. To explore the safety of Neovas BRS in interventional treatment of ide novo lesions in
           STEMI patients.

        3. To explore the safety of DCB in interventional treatment of de novo lesions in STEMI
           patients.
    
  